| Authors: |
Weeks LD; Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Savic S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Heiblig M; Hématologie clinique, Lyon-Sud Hospital, Hospices Civils de Lyon, Paris, France.; Université Claude Bernard, Lyon, France., Chowdhury O; Department of Haematology, Oxford University Hospitals' NHS Foundation Trust, Oxford, UK.; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Mekinian A; Sorbonne Université, Service de médecine interne, AP-HP, Hôpital Saint-Antoine, CEREMAIAA, Paris, France., Gurnari C; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.; Translational Haematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Ramchandren R; Division of Malignant Hematology and Medical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Georgin-Lavialle S; Department of Internal Medicine, DMU3ID, Tenon Hospital, Sorbonne Université, Paris, France.; CEREMAIA (French National Reference Center for Autoinflammatory Diseases), Paris, France.; ERN RITA (European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network), Paris, France., Ferrada MA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Buckley SA; RDMA Medicine Development, Sobi Inc., Waltham, MA, USA., Harder BG; RDMA Medicine Development, Sobi Inc., Waltham, MA, USA., Beck DB; Center for Human Genetics and Genomics, NYU School of Medicine, New York, NY, USA., Koster MJ; Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN, USA. |
